Financial Statements · Financial Reporting
Takeda Pharma OÜ
Official identifier 10323690Record date 31 Mar 2021
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2020
- Period start
- 1 Apr 2020
- Submitted date
- 19 Oct 2021
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 21,511,000 |
| Balance sheet | Cash and cash equivalents | 62,000 |
| Balance sheet | Current assets | 21,115,000 |
| Balance sheet | Current liabilities | 10,348,000 |
| Balance sheet | Equity | 10,974,000 |
| Balance sheet | Share capital at nominal value | 141,000 |
| Balance sheet | Non-current assets | 396,000 |
| Balance sheet | Non-current liabilities | 189,000 |
| Balance sheet | Retained earnings (loss) from previous periods | 8,229,000 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | 0 |
| Income statement scheme 1 | Revenue | 18,274,000 |
| Income statement scheme 1 | Annual period profit / loss | 1,256,000 |
| Income statement scheme 1 | Operating profit (loss) | 2,548,000 |
| Income statement scheme 1 | Profit (loss) before income tax | 2,547,000 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 8,229,000 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | 8,229,000 |
| Note: Labour costs | Employees | 11 |
| Note: Labour costs | Labour costs | -760,000 |
| Rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 0 |
| Rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 2,548,000 |
Linked company
Company: Takeda Pharma OÜ